0 CHECKOUT

PRODUCT FILTERS

REGION

39
22
22
21
21

COUNTRY

21
17
15
15
15

CATEGORIES

  • 33
  • 33
  • 18
  • 10
  • 7
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

6
8
23
89

PUBLISHED

0
5
27
89

PRODUCT TYPE

83
5
1

Search for: "China Biologic Products, Inc.-Therapeutic Competitors"

89 Products

Biologic Drug R&D in China - Current State and Future Development

The fast growth of the Chinese bio-pharmaceutical market has been prompting the rapid development of the entire Chinese bio-pharmaceutical industry, including R&D on biological medicines. In the recent...

Published:  May 2013
Price:  From

Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies

“Manufacturing of Biologics - Increasing Demand for Monoclonal Antibodies and Recombinant Proteins Drives Increases in Capacities and Innovative Production Technologies” provides the key data and analyzes...

Published:  September 2010
Price:  From

World Anti-Inflammatory Therapeutics - Market Opportunities and Forecasts, 2014 - 2020

Inflammation is triggered by the defense system of the body in response to harmful stimuli, damaged cells, irritants and microorganisms. Inflammation is the mechanism of innate immunity, which seeks...

Published:  June 2015
Price:  From

Comparison of Biopharmaceutical Industry between China and India 2013

It has been widely recognized that biopharmaceuticals have become not only a new class of therapeutics for those diseases previously treated with small molecule drugs but also a type of innovative treatment...

Published:  March 2013
Price:  From

The World Market for Biosimilars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition

The World Market for Biosimlars (EPO, G-CSF, HGH, Insulin, Interferon Alpha, Monoclonal Antibodies, Other), 4th Edition This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH,...

Published:  September 2013
Price:  From

The New Trends of Global Biomanufacturing Outsourcing

The fast growth of the global bio-pharmaceutical market has prompted all global major pharmaceutical companies to increase their R&D investment in biologics. The increasing availability of funding opportunities...

Published:  July 2014
Price:  From

The New Trends of Global Drug Discovery Outsourcing 2013

After having focused on the late stage drug development for several years, the global major pharmaceutical and biopharmaceutical companies have now all realized that they need to refocus on early stage...

Published:  September 2013
Price:  From

Global Biosimilars Industry 2015

Biosimilar is a term used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator...

Published:  February 2015
Price:  From

Deciphering Global Major Pharmaceutical Companies’ New Outsourcing Demands and Strategies

It has been publicly recognized that global major pharmaceutical companies have been involved in a series of challenges in the recent years. The latest patent cliff has resulted in significant overcapacities...

Published:  March 2015
Price:  From

Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014

Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014 Summary This, ‘Fibrinogen Deficiency (Factor I Deficiency) - Pipeline Review, H2 2014’, provides an overview of the Fibrinogen...

Published:  September 2014
Price:  From

Comparison of Innovative Drug R&D between China and India 2014

Besides their widely recognized strengths in pharmaceutical manufacturing, a growing number of Chinese and Indian companies are also being recognized for their improved skills and enhanced experiences...

Published:  January 2014
Price:  From

The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others)

This study, The World Market for Biosimilars, 4th Edition (EPO, G-CSF, HGH, Insulin, Interferon alpha, mAbs, Others), is designed to provide a comprehensive look at the various strategies being used...

Published:  September 2013
Price:  From

Cardiac Resynchronization Therapy (CRT) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Global Market Watch: BRICSS Cardiac Resynchronization Therapy (CRT) Devices market value is expected to reach US$455 million by 2016, primarily supported by the product types - Cardiac Resynchronization...

Published:  June 2014
Price:  From

Hemodynamic Monitoring Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Global Market Watch: BRICSS Hemodynamic Monitoring Devices market value is expected to reach US$281 million by 2016, primarily supported by the product types - Cardiac Output Monitoring Devices and...

Published:  November 2014
Price:  From

Cardiac Pacemakers - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Global Market Watch: BRICSS Cardiac Pacemakers market value is expected to reach US$903 million by 2016, primarily supported by the product types - Implantable Pacemakers and External Pacemakers China...

Published:  June 2014
Price:  From

Electrophysiology (EP) Laboratory Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Global Market Watch: BRICSS Electrophysiology (EP) Laboratory Devices market value is expected to reach US$123 million by 2016, primarily supported by the product types - X-Ray Systems, Remote Steering...

Published:  June 2014
Price:  From
Electrophysiology (EP) Laboratory Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 Electrophysiology (EP) Laboratory Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018 - Product Thumbnail Image

Diagnostic Electrophysiology (EP) Catheters - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Global Market Watch: BRICSS Diagnostic Electrophysiology Catheters market value is expected to reach US$710 million by 2016, primarily supported by the product types - Conventional EP Diagnostic Catheters,...

Published:  June 2014
Price:  From

Electrocardiogram (ECG) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Global Market Watch: BRICSS Electrocardiogram (ECG) Devices market value is expected to reach US$64 million by 2016, primarily supported by the product types - Resting ECG and Stress ECG China accounts...

Published:  June 2014
Price:  From

Cardiac Defibrillators - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Global Market Watch: BRICSS Cardiac Defibrillators market value is expected to reach US$1 5 billion by 2016, primarily supported by the product types - Implantable Cardioverter Defibrillators (ICD)...

Published:  June 2014
Price:  From

Electrophysiology (EP) Ablation Catheters - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

Global Market Watch: BRICSS Electrophysiology (EP) Ablation Catheters market value is expected to reach US$66 million by 2016, primarily supported by the product types - Radiofequency (RF) EP Ablation...

Published:  June 2014
Price:  From
Loading Indicator

Our Clients

  • Hewlett-Packard Company
  • Microsoft Corporation
  • Philips N.V.
  • SONY Corporation
  • Cypress Semiconductor Corporation
  • Panasonic Corporation